NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

All just share price $$ chatter to draw in poor retail.

This one got thirty likes but never mentioned here:

2018. So which is it?

Ms. Powers, CEO of NWBio commented "We are excited to see how the data are maturing, and we are grateful to our Scientific Advisory Board for their strong advice not to unblind the trial too early. Had we unblinded earlier, the opportunity to see the fuller extent of patient survival would have been lost, and the potential would never have been known."

"Until we reach data lock, the data will continue to mature. As we have cautioned before, the data may get either better or worse as they further mature. Also, the interim data are blinded aggregate data, and we do not know the breakdown between the treatment arm and the control arm of the trial."
Less